Nectar Life Sciences Limited — Ceftriaxone Exporter Profile
Indian Pharmaceutical Exporter · #13 for Ceftriaxone · $4.9M export value · DGFT Verified
Nectar Life Sciences Limited is the #13 Indian exporter of Ceftriaxone with $4.9M in export value and 115 verified shipments. Nectar Life Sciences Limited holds a 1.7% market share in Ceftriaxone exports across 15 countries. The company exports 3 pharmaceutical products worth $13.3M across 1 therapeutic categories.
Nectar Life Sciences Limited — Ceftriaxone Export Profile: Buyers & Destinations
Where Does Nectar Life Sciences Limited Export Ceftriaxone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $1.3M | 26 | 38.5% |
| SOUTH AFRICA | $726.5K | 24 | 21.6% |
| MALAYSIA | $269.0K | 29 | 8.0% |
| MYANMAR | $209.2K | 15 | 6.2% |
| ZAMBIA | $183.9K | 6 | 5.5% |
| PHILIPPINES | $125.4K | 4 | 3.7% |
| VIETNAM | $87.0K | 3 | 2.6% |
| ROMANIA | $75.4K | 3 | 2.2% |
| VIETNAM, DEMOCRATIC REP. OF | $62.2K | 2 | 1.9% |
| IVORY COAST | $61.6K | 3 | 1.8% |
Nectar Life Sciences Limited exports Ceftriaxone to 19 countries. The largest destination is MEXICO accounting for 38.5% of Nectar Life Sciences Limited's Ceftriaxone shipments, followed by SOUTH AFRICA (21.6%) and MALAYSIA (8.0%). These destinations reflect Nectar Life Sciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ceftriaxone from Nectar Life Sciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PRODUCTOS FARMACEUTICOS COLLINS, | MEXICO | $600.0K | 12 |
| INNOVATA PHARMACEUTICALS (PTY) LTD | SOUTH AFRICA | $486.1K | 18 |
| PRODUCTOS FARMACEUTICOS COLLINS | MEXICO | $300.0K | 6 |
| TO THE ORDER OF | MEXICO | $243.4K | 5 |
| HOVID BHD. | MALAYSIA | $212.0K | 22 |
| ALLEGENS COMPANY LIMITED | VIETNAM, DEMOCRATIC REP. OF | $149.2K | 5 |
| HOVID INC | PHILIPPINES | $125.4K | 4 |
| INNOVATA PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $120.3K | 3 |
| INNOVATA PHARMACEUTICALS PTY LTD | SOUTH AFRICA | $120.1K | 3 |
| DOCTOR PHARMA SARL | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $85.8K | 8 |
Nectar Life Sciences Limited supplies Ceftriaxone to 33 buyers globally. The largest buyer is PRODUCTOS FARMACEUTICOS COLLINS, (MEXICO), followed by INNOVATA PHARMACEUTICALS (PTY) LTD (SOUTH AFRICA) and PRODUCTOS FARMACEUTICOS COLLINS (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ceftriaxone Export Value and How Much Does Nectar Life Sciences Limited Contribute?
India exported $98.3M worth of Ceftriaxone through 11,257 shipments from 850 suppliers to 162 countries, serving 2,555 buyers globally. Nectar Life Sciences Limited contributes $4.9M to this total, accounting for 1.7% of India's Ceftriaxone exports. Nectar Life Sciences Limited ships Ceftriaxone to 19 countries through 33 buyers.
What Is the Average Shipment Value for Nectar Life Sciences Limited's Ceftriaxone Exports?
Nectar Life Sciences Limited's average Ceftriaxone shipment value is $42.6K per consignment, based on 115 shipments totaling $4.9M. The largest destination is MEXICO (38.5% of Nectar Life Sciences Limited's Ceftriaxone exports).
How Does Nectar Life Sciences Limited Compare to Other Indian Ceftriaxone Exporters?
Nectar Life Sciences Limited ranks #13 among 850 Indian Ceftriaxone exporters with a 1.7% market share. The top 3 exporters are INNOVA CAPTAB LIMITED ($30.0M), AUROBINDO PHARMA LTD ($9.2M), CIPLA LIMITED ($6.7M). Nectar Life Sciences Limited processed 115 shipments to 15 destination countries.
What Ceftriaxone Formulations Does Nectar Life Sciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TRAXICOLL (CEFTRIAXONE FOR INJECTION USP | $600.0K | 12 |
| FRAXONE 1G CEFTRIAXONE FOR INJECTION USP 1G ITEM CODE TENFRAX1G | $150.0K | 3 |
| TRAXICOLL CEFTRIAXONE FOR INJECTION USP | $150.0K | 3 |
| TRAXICOLL(CEFTRIAXONE FOR INJECTION USP1G)(1X50S)BATCH NOS : CXIC24001 TO CXIC24006, MFG. DATE: FEB 24, EXP. DATE : FEB | $143.4K | 3 |
| FRAXONE 1G (CEFTRIAXONE FOR INJECTION USP 1G)ITEM CODE-TENFRAX1G, BATCH NOS-IRIC24007 TO IRIC24012, MFG. DATE | $120.3K | 3 |
| HOFTREX 1 G (CEFTRIAXONE FOR INJECTION U | $97.9K | 3 |
| NECTRAM 1G (CEFTRIAXONE FOR INJECTION US | $92.8K | 3 |
| EMCEPH-1000 (CEFTRIAXONE FOR INJECTION USP 1 G) B.NO:AFIC24005 TO AFIC24007 MFGDT:JAN 2024 EXP DT:DEC 2026NOS | $75.4K | 3 |
| FRAXONE 250MG(CEFTRIAXONE 250MG INJECTION) ITEM CODE:TENFRAX250MG,BATCH NOS:IFIA23005,MFG DT :OCT-2023,EXP. DT:SEP-2026,NOS | $70.7K | 3 |
| NECTRAM CEFTRIAXONE FOR INJECTION USP 1G PEIC23002 M.OCT-2023 E.SEP-2026 | $55.7K | 2 |
Nectar Life Sciences Limited exports 84 distinct Ceftriaxone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TRAXICOLL (CEFTRIAXONE FOR INJECTION USP with 12 shipments worth $600.0K.
Regulatory Requirements: Exporting Ceftriaxone to Key Markets
What Nectar Life Sciences Limited must comply with to export Ceftriaxone to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Nectar Life Sciences Limited Compare to Nearest Ceftriaxone Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | INJECT CARE PARENTERALS PRIVATE LIMITED | $5.5M | 111 | 14 | $50.0K |
| 12 | SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI | $5.0M | 163 | 9 | $30.4K |
| 13 | NECTAR LIFE SCIENCES LIMITED ★ | $4.9M | 115 | 15 | $42.6K |
| 14 | SWISS PARENTERALS LIMITED | $4.6M | 154 | 22 | $29.6K |
| 7 | SAKAR HEALTHCARE LIMITED | $4.2M | 83 | 16 | $50.0K |
Nectar Life Sciences Limited ranks #13 among 850 Indian Ceftriaxone exporters. Average shipment value of $42.6K compared to the market average of $115.6K. The closest competitors by value are INJECT CARE PARENTERALS PRIVATE LIMITED and SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI.
Which Indian Ports Ship Ceftriaxone Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,199 | 10.7% |
| JNPT/ NHAVA SHEVA SEA | 819 | 7.3% |
| JNPT | 675 | 6.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 547 | 4.9% |
| DELHI AIR CARGO ACC (INDEL4) | 472 | 4.2% |
| MUNDRA SEA | 460 | 4.1% |
| DELHI AIR | 457 | 4.1% |
| SAHAR AIR | 451 | 4.0% |
What Other Advanced Antibiotics Products Does Nectar Life Sciences Limited Export?
Nectar Life Sciences Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Nectar Life Sciences Limited's Ceftriaxone Exports
The current geopolitical landscape presents significant challenges for Indian pharmaceutical exporters like Nectar Life Sciences Limited. The Israel-Iran conflict has led to disruptions in Middle East trade routes, particularly affecting the Red Sea and Suez Canal. These disruptions have resulted in increased shipping costs and extended transit times, posing risks to the timely delivery of pharmaceutical products. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these supply chain issues.
In the United States, recent tariff implementations have introduced additional complexities. In August 2025, the U.S. imposed broad tariffs on imports from over 60 countries, including India, with rates reaching up to 39%. These tariffs have significantly impacted Indian pharmaceutical exports, as the U.S. is a major market for generic drugs. The Federation of Indian Export Organisations highlighted that nearly 55% of India's exports to the U.S. are affected, leading to concerns about competitiveness and market access.
Conversely, the India–EFTA Trade and Economic Partnership Agreement (TEPA), effective from October 2025, offers a positive development. This agreement aims to eliminate or reduce tariffs on goods traded between India and EFTA countries (Iceland, Liechtenstein, Norway, and Switzerland), potentially opening new avenues for Indian pharmaceutical exports. However, compliance with stringent EU regulations, such as the Falsified Medicines Directive, remains a critical factor for market entry.
Nectar Life Sciences Limited — Regulatory Compliance & Quality Standards
The regulatory environment for Indian pharmaceutical exporters is becoming increasingly stringent. The U.S. Food and Drug Administration (FDA) has intensified inspections, with over 200 conducted in 2023 and plans to increase this number in 2024. Compliance with Good Manufacturing Practices (GMP) is paramount, as non-compliance can lead to import alerts and suspension of product registrations.
Nectar Life Sciences Limited's recent regulatory setbacks, including the AEMPS' Statement of Non-Compliance and the environmental penalty imposed by the National Green Tribunal, underscore the importance of robust quality assurance systems and environmental compliance. Addressing these issues is crucial for the company to maintain and expand its export markets.
About Nectar Life Sciences Limited
Nectar Life Sciences Limited exports 3 products worth $13.3M. Beyond Ceftriaxone, top products include Cefixime, Cefuroxime. View the complete Nectar Life Sciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ceftriaxone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ceftriaxone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Nectar Life Sciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 142 individual customs records matching Nectar Life Sciences Limited exporting Ceftriaxone, covering 84 formulations to 19 countries via 33 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 2,555+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ceftriaxone Export Data from Nectar Life Sciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Nectar Life Sciences Limited's Ceftriaxone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Nectar Life Sciences Limited
Full Company Profile →
3 products · $13.3M total trade · 1 categories
Ceftriaxone Stats
Company Overview
Top Products by Nectar Life Sciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Nectar Life Sciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ceftriaxone. For current shipment-level data, contact TransData Nexus.